4.6 Article

Natural History of Elderly-onset Ulcerative Colitis: Results from a Territory-wide Inflammatory Bowel Disease Registry

Journal

JOURNAL OF CROHNS & COLITIS
Volume 10, Issue 2, Pages 176-185

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ecco-jcc/jjv194

Keywords

Natural history; elderly-onset; ulcerative colitis

Funding

  1. Jesse Thomas Foundation
  2. AbbVie Hong Kong

Ask authors/readers for more resources

Background and Aims: Data on the natural history of elderly-onset ulcerative colitis [UC] are limited. We aimed to investigate clinical features and outcomes of patients with elderly-onset UC. Methods: Patients with a confirmed diagnosis of UC between 1981 and 2013, from 13 hospitals within a territory-wide Hong Kong Inflammatory Bowel Disease Registry, were included. Clinical features and outcomes of elderly-onset patients, defined as age >= 60 years at diagnosis, were compared with those of non-elderly-onset disease [< 60 years at diagnosis]. Results: We identified 1225 patients, of whom 12.8% [157/1225; 56.1% male] had elderly-onset UC. Median duration of follow-up was 11 years [interquartile range, 6-16 years]. Age-specific incidence of elderly-onset UC increased from 0.1 per 100 000 persons before 1991 to 1.3 per 100 000 persons after 2010. There were more ex-smokers [32.2% vs. 12.2%, p < 0.001] and higher proportion of comorbidities [p < 0.001] in elderly-onset than non-elderly-onset patients. Disease extent, corticosteroids, immunosuppressants use, and colectomy rates were similar between the two groups. Elderly-onset disease was an independent risk factor for cytomegalovirus infection [odds ratio 2.9, 95% confidence interval 1.6-5.2, p < 0.001]. More elderly-onset patients had Clostridium difficile infection [11.0% vs. 5.4%, p = 0.007], hospitalisation for UC exacerbation [50.6% vs. 41.8%, p = 0.037], colorectal cancer [3.2% vs. 0.9%, p = 0.033], all-cause mortality [7.0% vs. 1.0%, p < 0.001], and UC-related mortality [1.9% vs. 0.2%, p = 0.017] than non-elderly-onset patients. Conclusions: Elderly-onset UC patients are increasing in number. These patients have higher risk of opportunistic infections, hospitalisation, colorectal cancer, and mortality than non-elderly-onset patients. Management and therapeutic strategies in this special group need careful attention.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Correlations of Myeloperoxidase (MPO), Adenosine deaminase (ADA), C-C motif chemokine 22 (CCL22), Tumour necrosis factor alpha (TNFα) and Interleukin-6 (IL-6) mRNA expression in the nasopharyngeal specimens with the diagnosis and severity of SARS-CoV-2 infections

Kelvin Hei-Yeung Chiu, Cyril Chik-Yan Yip, Rosana Wing-Shan Poon, Kit-Hang Leung, Xin Li, Ivan Fan-Ngai Hung, Kelvin Kai-Wang To, Vincent Chi-Chung Cheng, Kwok-Yung Yuen

Summary: Cytokine dynamics in respiratory specimens of COVID-19 patients were studied in this retrospective case-control study. The study found that levels of MPO, ADA, CCL22, TNF alpha, and IL-6 mRNA were significantly higher in infected patients compared to controls, with ADA showing better performance. Additionally, severe COVID-19 patients had lower CCL22 mRNA levels. ADA may be a better biomarker for differentiating between infected and uninfected patients, while CCL22 has potential in stratifying the severity of COVID-19.

EMERGING MICROBES & INFECTIONS (2023)

Article Medicine, General & Internal

Comparison of Over-the-Scope Clips to Standard Endoscopic Treatment as the Initial Treatment in Patients With Bleeding From a Nonvariceal Upper Gastrointestinal Cause A Randomized Controlled Trial

James Y. W. Lau, Rui Li, Chen-huan Tan, Xiu-jing Sun, Hao-jun Song, Lan Li, Feng Ji, Bu-jiang Wang, Dong-tao Shi, Wai K. Leung, Imogen Hartley, Alan Moss, Karina Y. Y. Yu, Bing Y. Suen, Peng Li, Francis K. L. Chan

Summary: There is a clinically significant failure rate in current endoscopic methods for the control of acute nonvariceal bleeding. The role of over-the-scope clips (OTSCs) as the first treatment has not been defined. A multicenter, randomized controlled trial showed that compared to standard endoscopic hemostatic treatments, OTSCs can reduce the risk of further bleeding from nonvariceal upper gastrointestinal causes.

ANNALS OF INTERNAL MEDICINE (2023)

Article Gastroenterology & Hepatology

Whole genome sequencing reveals novel genetic mutations of Helicobacter pylori associating with resistance to clarithromycin and levofloxacin

Tao Lyu, Ka Shing Cheung, Zijie Deng, Li Ni, Chuan Chen, Juan Wu, Wai K. Leung, Wai Kay Seto

Summary: Whole genome sequencing of Helicobacter pylori revealed potential novel genetic mutations associated with clarithromycin and levofloxacin resistance, including fliJ and cheA genes, which may improve predictive accuracy for targeted sequencing tests in the future.

HELICOBACTER (2023)

Article Gastroenterology & Hepatology

Risk of hospitalization for upper gastrointestinal bleeding in Helicobacter pylori eradicated patients newly started on warfarin or direct oral anticoagulants: A population-based cohort study

Fang Jiang, Chengsheng Ju, Chuan-Guo Guo, Ka Shing Cheung, Bofei Li, Simon Y. K. Law, Wallis C. Y. Lau, Wai K. Leung

Summary: This study investigated the risk of hospitalization for upper gastrointestinal bleeding (UGIB) in patients who had received H. pylori eradication therapy and were newly started on warfarin or DOACs. The results showed that DOACs had a significantly lower risk of UGIB compared to warfarin in H. pylori-eradicated patients. Additionally, there was no significant difference in UGIB risk between H. pylori-eradicated and H. pylori-negative patients newly started on warfarin or DOACs.

HELICOBACTER (2023)

Article Biochemistry & Molecular Biology

Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients

Lui Ng, Ryan Wai-Yan Sin, David Him Cheung, Wai-Keung Leung, Abraham Tak-Ka Man, Oswens Siu-Hung Lo, Wai-Lun Law, Dominic Chi-Chung Foo

Summary: Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease that is increasing worldwide, and it is associated with colorectal polyps. This study aimed to investigate the potential of serum microRNAs (miRNAs) in identifying NAFLD in colorectal polyp patients. The results showed that a serum miRNA panel composed of four miRNA pairs significantly identified NAFLD in colorectal polyp patients, and its performance improved when patients with other concurrent metabolic disorders were removed from the analysis. The serum miRNA panel could be a potential diagnostic biomarker for screening NAFLD in colorectal polyp patients for early diagnosis and prevention of disease progression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Cardiac & Cardiovascular Systems

Sex-based differences in risk of ischaemic stroke or systemic embolism after BNT162b2 or CoronaVac COVID-19 vaccination in patients with atrial fibrillation: a self-controlled case series and nested case-control study

Xuxiao Ye, Caige Huang, Vincent Ka Chun Yan, Wei Kang, Min Fan, Gigi Kwan Chi Tsang, Clarissa Mung Yee Ho, Gregory Y. H. Lip, Kai-Hang Yiu, Hung-Fat Tse, Tiantian Ma, Xiwen Qin, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Carlos King Ho Wong, Eric Yuk Fai Wan, Xue Li, Cheuk Kwong Lee, Ivan Fan Ngai Hung, Ian Chi Kei Wong, Esther Wai Yin Chan

Summary: This study aimed to evaluate the risk of ischaemic stroke or systemic embolism and bleeding following COVID-19 vaccination in patients with atrial fibrillation (AF), with a focus on sex differences. The results showed that there was an increased risk of ischaemic stroke or systemic embolism in female patients with AF after receiving the first dose of BNT162b2 or CoronaVac. However, the risk was even higher after COVID-19 infection.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2023)

Article Immunology

A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults

Ruiqi Zhang, Kwok-Hung Chan, Pui Wang, Runhong Zhou, Henry Kwong-Chi Yau, Creany Ka-Wai Wong, Meena Wai-Lam Au, Anthony Raymond Tam, Chi-Tao Ng, Matthew Kwok-Chung Lou, Na Liu, Haode Huang, Shaofeng Deng, Rachel Chun-Yee Tam, Ying Liu, Teng Long, Hoi-Wah Tsoi, Miko K. W. Ng, Jian-Piao Cai, Kelvin Kai-Wang To, Man-Fung Yuen, Zhiwei Chen, Honglin Chen, Kwok-Yung Yuen, Ivan Fan-Ngai Hung

Summary: An intranasal COVID-19 vaccine, DelNS1-based RBD vaccines composed of H1N1 subtype (DelNS1-nCoV-RBD LAIV) was developed and tested for safety and immunogenicity in healthy adults. The study recruited 29 participants who were randomly assigned to receive the low or high dose vaccine or a placebo. The vaccine showed moderate mucosal immunogenicity and was well-tolerated, indicating the need for further clinical trials.

VACCINES (2023)

Article Immunology

Effect of Moderate to Severe Hepatic Steatosis on Vaccine Immunogenicity against Wild-Type and Mutant Virus and COVID-19 Infection among BNT162b2 Recipients

Ka Shing Cheung, Lok Ka Lam, Xianhua Mao, Jing Tong Tan, Poh Hwa Ooi, Ruiqi Zhang, Kwok Hung Chan, Ivan F. N. Hung, Wai Kay Seto, Man Fung Yuen

Summary: The study aimed to investigate the impact of non-alcoholic fatty liver disease (NAFLD) on the immunogenicity of the BNT162b2 vaccine against wild-type and variant strains of SARS-CoV-2, as well as infection outcome. The results showed that NAFLD patients who received two doses of the BNT162b2 vaccine had good immunogenicity against wild-type and delta variant strains, but poor immunogenicity against the omicron variant, and they were not at a higher risk of infection compared to the control group.

VACCINES (2023)

Review Gastroenterology & Hepatology

A Malaysian consensus report on the diagnosis and treatment of Helicobacter pylori infection

Khean-Lee Goh, Yeong Yeh Lee, Alex Hwong-Ruey Leow, Raja Affendi Raja Ali, Shiaw Hooi Ho, Sanjiv Mahadeva, Rosaida Hj Mohd Said, Raman Muthukaruppan Chettiar, Hoi Poh Tee

Summary: There are misconceptions in Malaysian clinical practice regarding the appropriate diagnostic method and treatment strategies for Helicobacter pylori infection. To address this, an expert panel of nine key opinion leaders in gastroenterology developed a set of consensus statements relevant to the Malaysian healthcare practice. The panel achieved consensus in three areas of H. pylori infection management: indications for testing, diagnosis, and treatment. They proposed 19 consensus statements, which can serve as a guide for physicians across various healthcare settings in Malaysia.

JGH OPEN (2023)

Editorial Material Gastroenterology & Hepatology

Editorial: Recognising the regional variations in profile of irritable bowel syndrome-better late than never! Authors' reply

Kee-Huat Chuah, Christopher J. Black, Vincent Tee, Sze-Zee Lim, Wen-Xuan Hian, Nur-Fazimah Sahran, Yeong-Yeh Lee, Sanjiv Mahadeva, Alexander C. Ford

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Public, Environmental & Occupational Health

Dietary patterns associated with colorectal cancer risk in the Malaysian population: a case-control study with exploratory factor and regression analysis

Ainaa Almardhiyah Abd Rashid, Lydiatul Shima Ashari, Nor Hamizah Shafiee, Raja Affendi Raja Ali, Lee Yeong Yeh, Mohd Razif Shahril, Hamid Jan Jan Mohamed

Summary: A study in Malaysia found that the processed diet pattern, characterized by a high intake of confectionaries and fast foods, was associated with an increased risk of colorectal cancer. Further research is needed to understand the impact of different dietary patterns on the gut microbiota associated with colorectal cancer, in order to develop prevention measures through lifestyle changes.

BMC PUBLIC HEALTH (2023)

Review Biochemistry & Molecular Biology

Antibiotic Resistance, Susceptibility Testing and Stewardship in Helicobacter pylori Infection

Ho-Yu Ng, Wai K. Leung, Ka-Shing Cheung

Summary: Despite the global decline in prevalence, efforts are needed to optimize H. pylori treatment regimens due to increasing antibiotic resistance. Advancements in sequencing technology have helped broaden our understanding of molecular mechanisms behind resistance and facilitated testing of antibiotic susceptibility. Establishing routine antibiotic susceptibility surveillance programs and enforcing antibiotic stewardship are important for managing H. pylori in a sustainable manner.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Neurosciences

A Pilot Study of Short-Course Oral Vitamin A and Aerosolised Diffuser Olfactory Training for the Treatment of Smell Loss in Long COVID

Tom Wai-Hin Chung, Hui Zhang, Fergus Kai-Chuen Wong, Siddharth Sridhar, Tatia Mei-Chun Lee, Gilberto Ka-Kit Leung, Koon-Ho Chan, Kui-Kai Lau, Anthony Raymond Tam, Deborah Tip-Yin Ho, Vincent Chi-Chung Cheng, Kwok-Yung Yuen, Ivan Fan-Ngai Hung, Henry Ka-Fung Mak

Summary: This pilot trial recruited long COVID patients with persistent olfactory dysfunction and found that a combination treatment of oral vitamin A and olfactory training was effective in improving olfactory function.

BRAIN SCIENCES (2023)

Article Gastroenterology & Hepatology

Long-term effect of Helicobacter pylori eradication on colorectal cancer incidences

Chuan-Guo Guo, Feifei Zhang, Fang Jiang, Lingling Wang, Yijun Chen, Wenxue Zhang, Anni Zhou, Shutian Zhang, Wai K. Leung

Summary: This population-based retrospective cohort study aimed to determine whether H. pylori eradication therapy reduces the risk of colorectal cancer (CRC). The results showed that the risk of CRC was initially higher in H. pylori-infected subjects but gradually decreased over time and became lower than the general population after 10 years of H. pylori eradication, particularly for rectal cancer.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2023)

Review Biotechnology & Applied Microbiology

Efficacy and safety of nab-paclitaxel in metastatic gastric cancer: a meta-analysis

Suhana Ahmad, Lidawani Lambuk, Naveed Ahmed, Ali Mussa, Vincent Tee, Ros Akmal Mohd Idris, Nur Fazimah Sahran, Yean Yean Chan, Rosline Hassan, Yeong Yeh Lee, Rohimah Mohamud

Summary: Nab-paclitaxel demonstrates good efficacy and safety in the treatment of metastatic gastric cancer, providing better disease response and longer survival.

NANOMEDICINE (2023)

No Data Available